Dr. Asker Asmi, M.D.
Critical Care Medicine (Critical Care Medicine (Internal Medicine) Physician)
- Medicare participating
At a glance
- Years since graduation
- 36
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 724
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Critical Care Medicine (Internal Medicine) Physician primary
MI license 4301070200
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Beaumont Hospital - Dearborn Dearborn, MI
- Trinity Health Oakland Hospital Pontiac, MI
- Wyandotte Hospital and Medical Center Wyandotte, MI
- Beaumont Hospital - Taylor Taylor, MI
- Corewell Health Trenton Hospital Trenton, MI
Medical groups
- Lung Associates PC (2 clinicians)
- Michigan Lung and Critical Care Specialists PC (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 724
- Services billed
- 2,434
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 828 | 508 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 241 | 91 |
| Established patient office or other outpatient visit, 40-54 minutes | 211 | 164 |
| Test to examine how well the lungs exchange gases | 188 | 186 |
| Critical care, first 30-74 minutes | 181 | 47 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 142 | 64 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 119 | 119 |
| Established patient office or other outpatient visit, 20-29 minutes | 110 | 97 |
| Test to measure expiratory airflow and volume | 103 | 102 |
| Test to determine lung volumes using gas dilution or washout | 103 | 102 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Riverview, MI | 447 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Riverview, MI | 389 |
| Advair Hfa (fluticasone propion/salmeterol) Other prescribers in Riverview, MI | 373 |
| Fluticasone-Salmeterol (fluticasone propion/salmeterol) Other prescribers in Riverview, MI | 314 |
| Ipratropium Bromide Other prescribers in Riverview, MI | 256 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Riverview, MI | 253 |
| Montelukast Sodium Other prescribers in Riverview, MI | 209 |
| Budesonide-Formoterol Fumarate (budesonide/formoterol fumarate) Other prescribers in Riverview, MI | 138 |
| Dulera (mometasone/formoterol) Other prescribers in Riverview, MI | 135 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Riverview, MI | 134 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 93 payments worth $1,814 in total to this clinician.
| GlaxoSmithKline, LLC. | $355 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $353 |
| Insmed, Inc. | $229 |
| Harmony Biosciences LLC | $186 |
| Grifols USA, LLC | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $89.28 |
| Regeneron Healthcare Solutions, Inc. | $67.61 |
| Pulmonx Corporation | $64.45 |
| Food and Beverage | $1,798 |
|---|---|
| Education | $16.24 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Insmed, Inc. Apr 22, 2025 | Education Arikayce · Respiratory · in-kind | $16.24 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.